PROCTER & GAMBLE HEALTH | SHARON BIO-MEDICINE | PROCTER & GAMBLE HEALTH/ SHARON BIO-MEDICINE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 37.3 | 0.1 | 38,422.0% | View Chart |
P/BV | x | 10.8 | - | - | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH SHARON BIO-MEDICINE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SHARON BIO-MEDICINE Mar-23 |
PROCTER & GAMBLE HEALTH/ SHARON BIO-MEDICINE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | NA | - | |
Low | Rs | 3,883 | NA | - | |
Sales per share (Unadj.) | Rs | 740.7 | 338.5 | 218.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 33.0 | 419.0% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 51.6 | 300.4% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | -1,024.9 | -43.7% | |
Shares outstanding (eoy) | m | 16.60 | 5.76 | 288.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0 | - | |
Avg P/E ratio | x | 33.5 | 0 | - | |
P/CF ratio (eoy) | x | 29.8 | 0 | - | |
Price / Book Value ratio | x | 10.3 | 0 | - | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 333 | 619.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,950 | 630.6% | |
Other income | Rs m | 184 | 45 | 412.7% | |
Total revenues | Rs m | 12,480 | 1,994 | 625.8% | |
Gross profit | Rs m | 3,247 | 254 | 1,280.6% | |
Depreciation | Rs m | 281 | 107 | 261.6% | |
Interest | Rs m | 8 | 1 | 1,241.9% | |
Profit before tax | Rs m | 3,142 | 190 | 1,653.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | - | |
Profit after tax | Rs m | 2,295 | 190 | 1,207.4% | |
Gross profit margin | % | 26.4 | 13.0 | 203.1% | |
Effective tax rate | % | 27.0 | 0 | - | |
Net profit margin | % | 18.7 | 9.7 | 191.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,758 | 666.2% | |
Current liabilities | Rs m | 6,791 | 3,391 | 200.3% | |
Net working cap to sales | % | 40.0 | -83.7 | -47.8% | |
Current ratio | x | 1.7 | 0.5 | 332.6% | |
Inventory Days | Days | 263 | 17 | 1,532.4% | |
Debtors Days | Days | 343 | 488 | 70.3% | |
Net fixed assets | Rs m | 10,617 | 1,372 | 773.7% | |
Share capital | Rs m | 166 | 12 | 1,442.2% | |
"Free" reserves | Rs m | 7,265 | -5,915 | -122.8% | |
Net worth | Rs m | 7,431 | -5,903 | -125.9% | |
Long term debt | Rs m | 0 | 5,580 | 0.0% | |
Total assets | Rs m | 22,330 | 3,130 | 713.3% | |
Interest coverage | x | 409.1 | 307.5 | 133.0% | |
Debt to equity ratio | x | 0 | -0.9 | -0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 88.4% | |
Return on assets | % | 10.3 | 6.1 | 169.3% | |
Return on equity | % | 30.9 | -3.2 | -959.3% | |
Return on capital | % | 42.4 | -59.0 | -71.9% | |
Exports to sales | % | 0 | 73.2 | 0.0% | |
Imports to sales | % | 13.1 | 7.5 | 175.0% | |
Exports (fob) | Rs m | NA | 1,428 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 145 | 1,103.7% | |
Fx inflow | Rs m | 1,465 | 1,428 | 102.6% | |
Fx outflow | Rs m | 1,605 | 166 | 969.8% | |
Net fx | Rs m | -140 | 1,263 | -11.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 411 | 574.0% | |
From Investments | Rs m | -215 | -28 | 775.3% | |
From Financial Activity | Rs m | -985 | NA | -428,130.4% | |
Net Cashflow | Rs m | 1,160 | 384 | 302.4% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 99,850.0% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 100.0 | 48.2% | |
Shareholders | 56,778 | 24,837 | 228.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SHARON BIO-MEDICINE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.56% | -1.53% | 0.58% |
1-Month | 2.61% | -8.29% | 3.13% |
1-Year | -4.47% | -41.85% | 55.61% |
3-Year CAGR | -6.27% | -33.57% | 13.89% |
5-Year CAGR | 1.20% | -40.63% | 21.73% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SHARON BIO-MEDICINE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SHARON BIO-MEDICINE the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SHARON BIO-MEDICINE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SHARON BIO-MEDICINE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SHARON BIO-MEDICINE.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.